Publicaciones (22) Publicaciones de Nuria Martínez Sáez

2024

  1. Structure-Guided Approach for the Development of MUC1-Glycopeptide-Based Cancer Vaccines with Predictable Responses

    JACS Au, Vol. 4, Núm. 1, pp. 150-163

2023

  1. First Generation of Antioxidant Precursors for Bioisosteric Se-NSAIDs: Design, Synthesis, and In Vitro and In Vivo Anticancer Evaluation

    Antioxidants, Vol. 12, Núm. 9

  2. Seleno-Analogs of Scaffolds Resembling Natural Products a Novel Warhead toward Dual Compounds

    Antioxidants, Vol. 12, Núm. 1

2022

  1. Norbornene and Related Structures as Scaffolds in the Search for New Cancer Treatments

    Pharmaceuticals, Vol. 15, Núm. 12

2019

  1. One-pot stapling of interchain disulfides of antibodies using an isobutylene motif

    Organic and Biomolecular Chemistry, Vol. 17, Núm. 7, pp. 2005-2012

2018

  1. Chemo- and Regioselective Lysine Modification on Native Proteins

    Journal of the American Chemical Society, Vol. 140, Núm. 11, pp. 4004-4017

  2. Enhanced Permeability and Binding Activity of Isobutylene-Grafted Peptides

    Chembiochem : a European journal of chemical biology, Vol. 19, Núm. 1, pp. 48-52

2017

  1. In situ characterization of advanced glycation end products (AGEs) in collagen and model extracellular matrix by solid state NMR

    Chemical Communications, Vol. 53, Núm. 100, pp. 13316-13319

  2. Oxetane Grafts Installed Site-Selectively on Native Disulfides to Enhance Protein Stability and Activity In Vivo

    Angewandte Chemie International, Vol. 56, Núm. 47, pp. 14963-14967

  3. Principles of mucin structure: Implications for the rational design of cancer vaccines derived from MUC1-glycopeptides

    Chemical Society Reviews, Vol. 46, Núm. 23, pp. 7154-7175

  4. Site-Selective Modification of Proteins with Oxetanes

    Chemistry - A European Journal, Vol. 23, Núm. 27, pp. 6483-6489

  5. The Use of Fluoroproline in MUC1 Antigen Enables Efficient Detection of Antibodies in Patients with Prostate Cancer

    Journal of the American Chemical Society, Vol. 139, Núm. 50, pp. 18255-18261

2016

  1. Mucin Architecture behind the Immune Response: Design and Evaluation of an Antitumor Vaccine Derived from an Unnatural MUC1 Fragment

    Chemical Science, Vol. 7, Núm. 3, pp. 2294

  2. Stoichiometric and irreversible cysteine-selective protein modification using carbonylacrylic reagents

    Nature Communications, Vol. 7

  3. Tn Antigen Mimics Based on sp2-Iminosugars with Affinity for an anti-MUC1 Antibody

    Organic Letters, Vol. 18, Núm. 15, pp. 3890-3893

2015

  1. Collagen labelling with an azide-proline chemical reporter in live cells

    Chemical Communications, Vol. 51, Núm. 25, pp. 5250-5252

  2. Deciphering the Non-Equivalence of Serine and Threonine O-glycosylation Points: Implications for Molecular Recognition of the Tn Antigen by an anti-MUC1 Antibody

    Angewandte Chemie International, Vol. 54, Núm. 34, pp. 9830

  3. Detection of tumor-associated glycopeptides by Lectins: The peptide context modulates carbohydrate recognition

    ACS chemical biology, Vol. 10, Núm. 3, pp. 747-756

2014

  1. Conformational analysis of peptides and glycopeptides derived from the consensus sequence for β-O-glucosylation

    Current Topics in Medicinal Chemistry, Vol. 14, Núm. 23, pp. 2712-2721

  2. Designing non-natural cancer vaccines by replacing the methyl group of Thr-10 in MUC1 derivatives

    XI Carbohydrate Symposium